Skip to main content
. 2021 Aug 3;11(8):e042480. doi: 10.1136/bmjopen-2020-042480

Figure 1.

Figure 1

Time to discontinuation of disease-modifying treatments (DMTs) in patients with relapsing remitting multiple sclerosis for time periods 2010–2012, 2013–2015, 2016–2018; all DMT (A) and by injectables (B), orals (C), infusions (D).